%0 Journal Article %T Survival of Patients with Small-Cell Lung Cancer Treated at Tertiary Hospitals in the East of Thailand, 2007-2016: A Retrospective Study %A Sitthi Sukauichai %A Chokaew Tovanabutra %A Thapana Tangchewinsirikul %A Sirentra Wanglikitkoon %A Kittisak Chomprasert %A Teerayuth Namkanitsorn %A Passakorn Wanchaijiraboon %A Annop Kittiwarawut %J Advances in Lung Cancer %P 1-14 %@ 2169-2726 %D 2019 %I Scientific Research Publishing %R 10.4236/alc.2019.81001 %X Objective: The objective of the study was to determine the survival of patients with small-cell lung cancer treated at tertiary hospitals in the East of Thailand. Materials and methods: The researchers conducted this retrospective study by reviewing medical records of patients with small-cell lung cancer treated at Chonburi Cancer Hospital and Prapokklao Hospital from January 2007 to December 2016 and monitored via follow-up until December 2018. Results: This study enrolled 54 patients with a median follow-up time of 8.5 months. The median age of patients was 63 years old. Most patients were male (83.3%) and had a history of smoking (90.7%), and 31.4% had clinical superior vena cava obstruction at initial treatment. The Eastern Cooperative Oncology Group performance status 0-1 was noted for 61.1% of the study population. Median survival time of patients with limited-stage and extensive-stage small cell lung cancer who received systemic chemotherapy and/or radiotherapy was 17.01 months (95% CI, 12.01 - 22.01) and 8.14 months (95% CI, 7.19 - 9.10), respectively, and that of patients %K Survival %K Small Cell Lung Cancer %K Tertiary Hospitals %K Thailand %U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=98208